Literature DB >> 12648453

Granzyme B-induced apoptosis requires both direct caspase activation and relief of caspase inhibition.

Ing Swie Goping1, Michele Barry, Peter Liston, Tracy Sawchuk, Gabriela Constantinescu, Karolina M Michalak, Irene Shostak, Darren L Roberts, Allison M Hunter, Robert Korneluk, R Chris Bleackley.   

Abstract

Cytotoxic lymphocytes employ Granzyme B as a potent initiator of apoptosis to cleave and activate effector caspases. Unexpectedly, cells transfected with Bcl-2 were resistant to granzyme B-induced killing, suggesting that a mitochondrial pathway was critical. Utilizing cells expressing a dominant-negative caspase 9, the current study demonstrated that caspase activation via the apoptosome was not required. Indeed, cleavage of caspase 3 to p20 still occurred in Bcl-2-transfectants but processing to p17 was blocked. This blockade was recapitulated by the Inhibitor-of-Apoptosis-Protein XIAP and relieved by Smac/DIABLO. Thus granzyme B mediates direct cleavage of caspase 3 and also activates mitochondrial disruption, resulting in the release of proapoptotic proteins that suppress caspase inhibition. Engagement of both pathways is critical for granzyme-induced killing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12648453     DOI: 10.1016/s1074-7613(03)00032-3

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  46 in total

1.  Granzyme B-induced mitochondrial ROS are required for apoptosis.

Authors:  G Jacquemin; D Margiotta; A Kasahara; E Y Bassoy; M Walch; J Thiery; J Lieberman; D Martinvalet
Journal:  Cell Death Differ       Date:  2014-10-31       Impact factor: 15.828

2.  A proteomic approach for the discovery of protease substrates.

Authors:  Andrew J Bredemeyer; Renate M Lewis; James P Malone; Alan E Davis; Julia Gross; R Reid Townsend; Timothy J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

Review 3.  A quarter century of granzymes.

Authors:  C L Ewen; K P Kane; R C Bleackley
Journal:  Cell Death Differ       Date:  2011-11-04       Impact factor: 15.828

4.  The major human and mouse granzymes are structurally and functionally divergent.

Authors:  Dion Kaiserman; Catherina H Bird; Jiuru Sun; Antony Matthews; Kheng Ung; James C Whisstock; Philip E Thompson; Joseph A Trapani; Phillip I Bird
Journal:  J Cell Biol       Date:  2006-11-20       Impact factor: 10.539

Review 5.  Use of protease proteomics to discover granzyme B substrates.

Authors:  Andrew J Bredemeyer; R Reid Townsend; Timothy J Ley
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 6.  Apoptosis: a review of programmed cell death.

Authors:  Susan Elmore
Journal:  Toxicol Pathol       Date:  2007-06       Impact factor: 1.902

Review 7.  Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease.

Authors:  Dominic P Del Re; Dulguun Amgalan; Andreas Linkermann; Qinghang Liu; Richard N Kitsis
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

8.  Landscape of innate immune system transcriptome and acute T cell-mediated rejection of human kidney allografts.

Authors:  Franco B Mueller; Hua Yang; Michelle Lubetzky; Akanksha Verma; John R Lee; Darshana M Dadhania; Jenny Z Xiang; Steven P Salvatore; Surya V Seshan; Vijay K Sharma; Olivier Elemento; Manikkam Suthanthiran; Thangamani Muthukumar
Journal:  JCI Insight       Date:  2019-07-11

Review 9.  T Cells and Regulated Cell Death: Kill or Be Killed.

Authors:  Johan Spetz; Adam G Presser; Kristopher A Sarosiek
Journal:  Int Rev Cell Mol Biol       Date:  2018-08-29       Impact factor: 6.813

10.  Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity.

Authors:  Gregory J Baker; Peter Chockley; Viveka Nand Yadav; Robert Doherty; Michael Ritt; Sivaraj Sivaramakrishnan; Maria G Castro; Pedro R Lowenstein
Journal:  Cancer Res       Date:  2014-07-18       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.